Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SRDX holding history

Surmodics Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRDX overviewAll 13F holders of SRDXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SRDX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−32,251−100.0%Sold outHolders
Q3 202532,251$964.0K<0.1%−390,473−92.4%ReducedHolders
Q2 2025422,724$12.6M<0.1%+356,982+543.0%AddedHolders
Q1 202565,742$2.01M<0.1%+58,835+851.8%AddedHolders
Q4 20246,907$273.5K<0.1%+3,374+95.5%AddedHolders
Q3 20243,533$137.0K<0.1%−1,260−26.3%ReducedHolders
Q2 20244,793$201.5K<0.1%−9,882−67.3%ReducedHolders
Q1 202414,675$430.6K<0.1%−241−1.6%ReducedHolders
Q4 202314,916$542.2K<0.1%+4,742+46.6%AddedHolders
Q3 202310,174$326.5K<0.1%−4,312−29.8%ReducedHolders
Q2 202314,486$453.6K<0.1%+7,513+107.7%AddedHolders
Q1 20236,973$158.8K<0.1%+2,658+61.6%AddedHolders
Q4 20224,315$147.2K<0.1%+2,025+88.4%AddedHolders
Q3 20222,290$70.0K<0.1%+1,340+141.1%AddedHolders
Q2 2022950$35.0K<0.1%−4,423−82.3%ReducedHolders
Q1 20225,373$243.0K<0.1%−5,222−49.3%ReducedHolders
Q4 202110,595$510.0K<0.1%+6,047+133.0%AddedHolders
Q3 20214,548$253.0K<0.1%−1,707−27.3%ReducedHolders
Q2 20216,255$340.0K<0.1%−2,044−24.6%ReducedHolders
Q1 20218,299$465.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.